Financial statements Ovopol
Balance sheet data of OVOPOL
|
Year
|
2018
|
2019
|
2020
|
2022
|
2024
|
2025
|
|---|---|---|---|---|---|---|
| Total assets | 79 394 651,43 | 76 268 610,03 | 97 818 198,17 | 119 639 072,31 | 136 809 041,43 | 144 693 174,93 |
| A. Fixed assets | 38 235 983,14 | 38 291 809,05 | 55 395 989,30 | 65 360 155,80 | 58 208 155,77 | 51 162 035,01 |
| B. Current assets | 41 158 668,29 | 37 976 800,98 | 42 422 208,87 | 54 278 916,51 | 78 600 885,66 | 93 531 139,92 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 79 394 651,43 | 76 268 610,03 | 97 818 198,17 | 119 639 072,31 | 136 809 041,43 | 144 693 174,93 |
| A. Equity | 45 769 898,43 | 46 927 322,32 | 51 158 534,99 | 69 506 065,90 | 83 552 044,23 | 85 498 766,92 |
| B. Liabilities and provisions for liabilities | 33 624 753,00 | 29 341 287,71 | 46 659 663,18 | 50 133 006,41 | 53 256 997,20 | 59 194 408,01 |
| I. Long-term liabilities | 682 149,65 | 2 632 000,00 | 12 366 746,47 | 8 604 901,32 | 3 059 159,45 | 1 815 601,60 |
| II. Short-term liabilities | 22 592 995,66 | 17 885 567,99 | 22 161 291,73 | 23 893 030,05 | 33 569 083,81 | 39 920 726,25 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD